Prelude Therapeutics
Prelude Therapeutics is a cancer Treatments founded in 2016.
2
Funding Rounds
$110.0m
Money raised
| Name | Phone | Social networks | |
|---|---|---|---|
| Da*** Bo**** | - | - | - |
| Ma**** Ba**** | - | - | |
| Pa** A. Fr****** | - | - | - |
| Ma*** C. Di** | - | - | |
| Kr** Va*** | - | - | - |
| Vi**** Sa**** | - | - | - |
| Ju**** Ba*** | - | - |
Funding series
Funding Series Analysis
The company Prelude Therapeutics has raised a total of $60m in funding over 2 rounds.
Key Insights:
- Prelude Therapeutics Series B round, June 2019: $60m
- Prelude Therapeutics Inc funding round, August 2020: $50m
Prelude Therapeutics Series B round, June 2019
$60m
Prelude Therapeutics Inc funding round, August 2020
$50m
Industries
Prelude Therapeutics is active in the following industries:
- Biotechnology
- Biology
- Biopharmaceutical
- Healthcare
- Medicine
- Oncology
- Speciality chemicals
- Cancer
- Technology
- Engineering
- Biomedical engineering
- Internal medicine